Does TRILACICLIB Cause White blood cell count decreased? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of White blood cell count decreased have been filed in association with TRILACICLIB (COSELA). This represents 8.0% of all adverse event reports for TRILACICLIB.
18
Reports of White blood cell count decreased with TRILACICLIB
8.0%
of all TRILACICLIB reports
1
Deaths
14
Hospitalizations
How Dangerous Is White blood cell count decreased From TRILACICLIB?
Of the 18 reports, 1 (5.6%) resulted in death, 14 (77.8%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is White blood cell count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
Haemorrhage (11)
What Other Drugs Cause White blood cell count decreased?
PALBOCICLIB (11,273)
LENALIDOMIDE (9,996)
FINGOLIMOD (3,597)
CLOZAPINE (3,454)
POMALIDOMIDE (3,328)
CYCLOPHOSPHAMIDE (2,868)
RITUXIMAB (2,268)
METHOTREXATE (2,107)
RIBAVIRIN (1,970)
VENETOCLAX (1,913)
Which TRILACICLIB Alternatives Have Lower White blood cell count decreased Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE